4.5 Article

Early Start of Dialysis Has No Survival Benefit in End-Stage Renal Disease Patients

Journal

JOURNAL OF KOREAN MEDICAL SCIENCE
Volume 27, Issue 10, Pages 1177-1181

Publisher

KOREAN ACAD MEDICAL SCIENCES
DOI: 10.3346/jkms.2012.27.10.1177

Keywords

End Stage Renal Disease; Glomerular Filtration Rate; Renal Dialysis; Mortality; Peritoneal Dialysis

Funding

  1. Gachon University Gil Hospital
  2. National Research Foundation of Korea [2011-0008605]
  3. National Research Foundation of Korea [2011-0008605] Funding Source: Korea Institute of Science & Technology Information (KISTI), National Science & Technology Information Service (NTIS)

Ask authors/readers for more resources

The timing for dialysis initiationis still debated. The aim of this study was to compare mortality rates, using a propensity-score approach, in dialysis patients with early or late starts. From January 2000 to June 2009, incident adult patients (n = 836) starting dialysis for end-stage renal disease (ESRD) were enrolled. The patients were assigned to either an early- or late-start group depending on the initiation time of the dialysis. After propensity-score-basedmatching, 450 patients remained. At the initiation of dialysis, the mean estimated glomerular filtration rate (eGFR) was 11.1 ml/min/1.73 m(2) in the early-start group compared with 6.1 ml/min/1.73 m(2) in the late-start group. There were no significant differences in survival between the patients in the early- and late-start groups (Log rank tests P = 0.172). A higher overall mortality risk was observed in the early-start group than in the late-start group for the patients aged >= 70 yr (hazard ratio [HR]: 3.29; P = 0.048) and/or who had albumin levels >= 3.5 g/dL (HR: 2.53; P = 0.046). The survival of the ESRD patients was comparable between the patients in the early and late-start groups. The time to initiate dialysis should be determined based on clinical findings as well as the eGFR.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available